Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-29 @ 6:20 AM
Study NCT ID:
NCT01156532
Status:
TERMINATED
Last Update Posted:
2014-08-25
First Post:
2010-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-08
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-01
First Submit QC Date:
None
Study First Post Date:
2010-07-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-08-08
Results First Submit QC Date:
None
Results First Post Date:
2014-08-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-08-08
Last Update Post Date:
2014-08-25
Last Update Post Date Type:
ESTIMATED